Association of SYT-SSX fusion types with proliferative activity and prognosis in synovial sarcoma

Modern Pathology

Volumn 13, Issue 5, 2000, Pages 482-488

  Inagaki, Hiroshi ^a   Nagasaka, Tetsuro ^b   Otsuka, Takanobu ^a   Sugiura, Eiji ^b   Nakashima, Nobuo ^b   Eimoto, Tadaaki ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Ki 67; Mitotic activity; Proliferation; Reverse transcription polymerase chain reaction; Survival; Synovial sarcoma; SYT SSX

Indexed keywords

KI 67 ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; CANCER SURVIVAL; CELL PROLIFERATION; CHROMOSOME 18; CHROMOSOME BREAKAGE; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; FEMALE; GENE FUSION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MITOSIS RATE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNOVIAL SARCOMA;

EID: 0034078438     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880083     Document Type: Article

References (27)

1. Enzinger FM, Weiss SW. Synovial sarcoma. In: Enzinger FM, Weiss SW, editors. Soft tissue tumors. 3rd ed. St. Louis: Mosby; 1995. p. 757-86.
2. Ladanyi M. The emerging molecular genetics of sarcoma translocation. Diagn Mol Pathol 1995;4:162-73.
3. Sorensen PHB, Triche TJ. Gene fusions encoding chimeric transcription factors in solid tumors. Semin Cancer Biol 1996;7:3-14.
4. Clark J, Rocques PJ, Crew AJ, Gill S, Shipley J, Chan AML, et al. Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nat Genet 1994;7:502-8.
5. Crew AJ, Clark J, Fisher C, Gill S, Grimer R, Chand A, et al. Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma. EMBO J 1995;14:2333-40.
6. Fligman J, Lonardo F, Jhanwar SC, Gerad WL, Woodruff J, Ladanyi M. Molecular diagnosis of synovial sarcoma and characterization of a variant SYT-SSX2 fusion transcript. Am J Pathol 1995;147:1592-9.
7. Kawai A, Woodruff J, Healey JH, Brennean MF, Antonescu CR, Ladanyi M. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med 1998;338:153-60.
8. Argani P, Zakowski MF, Klimstra DS, Rosai J, Ladanyi M. Detection of the SYT-SSX chimeric RNA of synovial sarcoma in paraffin-embedded tissue and its application in problematic cases. Mod Pathol 1998;11:65-71.
9. Tsuji S, Hisaoka M, Morimitsu Y, Hashimoto H, Shimajiri S, Komiya S, et al. Detection of SYT-SSX fusion transcripts in synovial sarcoma by reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues. Am J Pathol 1998;153:1807-12.
10. Inagaki H, Murase T, Otsuka T, Eimoto T. Detection of SYT-SSX fusion transcript in synovial sarcoma using archival cytologic specimens. Am J Clin Pathol 1999;111:528-33.
11. Gure AO, Tureci O, Sahin U, Tsang S, Scanlan MJ, Jager E, et al. SSX: a multigene family with several members transcribed in normal testis and with human cancer. Int J Cancer 1997;72:965-71.
12. Skytting B, Nilsson G, Brodin B, Xie Y, Lundeberg J, Uhlen M, et al. A novel fusion gene, SYT-SSX4, in synovial sarcoma [letter]. J Natl Cancer Inst 1999;91:974-5.
13. Inagaki H, Murase T, Shimokawa K, Eimoto T. Expression of MIB-1 antigen and P-glycoprotein in synovial sarcoma [abstract]. Proc Jpn Soc Pathol 1999;88:280 (in Japanese).
14. Nilsson G, Skytting B, Xie Y, Brodin B, Perfekt R, Mandahl N, et al. The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome. Cancer Res 1999;59:3180-4.
15. Lopes JM, Hannisdal E, Bjerkehagen B, Bruland OS, Danielsen HE, Pettersen EO, et al. Synovial sarcoma. Evaluation of prognosis with emphasis on the study of DNA ploidy and proliferation (PCNA and Ki-67) markers. Anal Cell Pathol 1998;16:45-62.
16. Taubert H, Meye A, Wurl P. Prognosis is correlated with p53 mutation type for soft tissue sarcoma patients. Cancer Res 1996;56:4134-6.
17. Suster S, Fisher C, Moran CA. Expression of bcl-2 oncoprotein in benign and malignant spindle tumors of soft tissue, skin, serosal surfaces, and gastrointestinal tract. Am J Surg Pathol 1998;22:863-72.
18. Oda Y, Hashimoto H, Tsuneyoshi M, Takeshita S. Survival in synovial sarcoma. A multivariate study of prognostic factors with special emphasis on the comparison between death and long-term survival. Am J Surg Pathol 1993;17:35-44.
19. de Alava E, Kawal A, Healey JH, Fligman I, Meyers PA, Juvos AG, et al. EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. J Clin Oncol 1998;16:1248-55.
20. Kelly KM, Womer RB, Sorensen PHB, Xiong QB, Barr FG. Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma. J Clin Oncol 1997;15: 1831-6.
21. Gerdes J, Li L, Schlueter C, Duchrow M, Wohlenberg C, Gerlach C, et al. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 1991;138:867-73.
22. Brett D, Whitehouse S, Antonson P, Shipley J, Cooper C, Goodwin G. The SYT protein involved in the t(X;18) synovial sarcoma translocation is a transcriptional activator localised in nuclear bodies. Hum Mol Genet 1997;6:1559-64.
23. Thaete C, Brett D, Monaghan P, Whitehouse S. Functional domains of the SYT and SYT-SSX synovial sarcoma translocation proteins and co-localization with the SNF protein BRM in the nucleus. Hum Mol Genet 1999;8:585-91.
24. Polyak K, Kato JY, Solomom MJ, Sherr CJ, Massague J, Roberts JM, et al. p27 Kip1, a cyclin-Cdk inhibitor links transforming growth factor-beta and contact inhibition to cell arrest. Genes Dev 1994;8:9-22.
25. Steeg PS, Abram JS. Cancer prognostics: post, present and p27. Nat Med 1997;3:152-4.
26. Lloyd RV, Erickson LA, Jin L, Kulig E, Qian X, Cheville JC, et al. p27/Kip1. A multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol 1999;154:313-23.
27. Shipley J, Crew J, Birdsall S, Gill S, Clark J, Fisher C, et al. Interphase fluorescence in situ hybridization and reverse transcription polymerase chain reaction as a diagnostic aid for synovial sarcoma. Am J Pathol 1996;148:559-67.